•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Ivonescimab Plus Chemotherapy Demonstrates Overall Survival Superiority Compared to Durvalumab Plus Chemotherapy in First-Line Treatment of Patients with Advanced Biliary Tract Cancer in HARMONi-GI1 S
Lunit and Summit Therapeutics Announce Agreement to Apply AI-powered SCOPE IO Platform for Tumor Microenvironment Analysis in Immuno-Oncology Development
JJ Lin, Tia Ray & Lil Ghost Take the Formula 1 Singapore Grand Prix Stage With Support From TME
JJ Lin, Tia Ray & Lil Ghost Take the Formula 1 Singapore Grand Prix Stage With Support From TME
Why this little known Chinese chipmaker has caused a global stock rout
Tencent Music Entertainment Group to Report Third Quarter 2026 Financial Results on November 17, 2026
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
Summit Therapeutics Announces Clinical Trial Collaboration with AstraZeneca and Daiichi Sankyo to Evaluate Ivonescimab in Combination with TROP2-Directed ADC Datroway
Major Indexes Slide as Investors Digest Consumer Sentiment Data
Tencent Music: The Market Is Pricing In Too Much Weakness
Tencent Music's 2026 Outlook: $400 Million Share Repurchase Program Reflects Financial Discipline
Ivonescimab Monotherapy Demonstrates a Statistically Significant & Clinically Meaningful Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in Akeso's HARMONi-2 Study Condu
Tencent Music Entertainment Group Announces Closing of US$1,000 Million Notes Offering
BIGBANG 2026-2027 WORLD TOUR < XX: COSMOS > IN HONG KONG Officially Announced
Tencent Music Entertainment Group Announces Pricing of US$1,000 Million Notes Offering
Tencent Music Entertainment Group Announces Notes Offering
Tencent Music Entertainment Group Sponsored ADR (NYSE:TME) Receives Average Rating of “Hold” from Brokerages
Comparing NEXON (OTCMKTS:NEXOY) and Tencent Music Entertainment Group (NYSE:TME)
Ivonescimab Plus Chemotherapy Global Phase III HARMONi Primary Analysis Results Published in The Lancet Oncology
Why Tencent Music Stock Sank This Week
Already premium?